Key result
Verapamil showed no difference compared to digoxin for heart rate control in new-onset atrial fibrillation, achieving best rate control, respectively.
Why the study?
Does intravenous verapamil improve acute heart rate control compared to intravenous digoxin in patients with new-onset atrial fibrillation and rapid ventricular response?
Observational (n=60)
No
Does intravenous verapamil improve acute heart rate control compared to intravenous digoxin in patients with new-onset atrial fibrillation and rapid ventricular response?
Intravenous verapamil and digoxin are equally effective for achieving acute heart rate control in emergency department patients with new-onset atrial fibrillation.
Answers are grounded in this paper and cite their sources.
No difference observed with verapamil versus digoxin for acute rate control; should not yet change practice and leaves open need for RCTs.
PURPOSE: Atrial fibrillation (AF) is one of the most common types of sustained dysrhythmia and there are some disagreements about its treatment. The goals of AF treatment include the control of ventricular rate, the establishment of sinus rhythm and the prevention of thromboembolic events. In this study, the effect of verapamil was compared to digoxin on heart rate control in patients with AF. METHODS: This descriptive study was conducted in an emergency department (ED) in Iran. Sixty patients with a new onset AF and rapid ventricular response receiving digoxin or verapamil were included and observed. RESULTS: Two thirty-patient groups receiving verapamil or digoxin were evaluated. The heart rate was significantly decreased in both groups (p = 0.002); however, the cardioversion was not noticed in both of them. The best rate control in verapamil and digoxin groups was observed after 5.9 mg (46.7%) and 0.6 mg (36.7%), respectively. CONCLUSION: Administration of verapamil in comparison with digoxin has no difference to control the heart rate in AF patients. It should be taken into consideration that prospective randomized studies should be conducted to identify the efficacy and select the best of these two drugs to treat AF patients.
No takes yet. Share an insight, caveat, or question.
Moghadam et al. (2012) conducted an observational in Atrial fibrillation (n=60). Verapamil vs. Digoxin was evaluated on Heart rate control (p=0.002). Verapamil showed no difference compared to digoxin for heart rate control in new-onset atrial fibrillation, achieving best rate control, respectively.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: